… Dialysis patients have a mixture of calcified intimal atherosclerotic lesions and medial
calcinosis.3, 4 Despite advances in the management of cardiovascular disease, patients with …

… patient group. Recent evidence demonstrates that chronic inflammation, a non-traditional risk
factor which is a commonly observed in dialysis patients… several pathogenetic mechanisms…

… plasma of dialysis patients that are generally absent in normal control subjects [46]. This
study revealed that more than 30 polypeptides show significant changes in dialysis patients as …

… in dialysis patients remains unacceptably high. The most common cause of death in ESRD
patients (… In the future, it should be worthwhile to investigate more precisely the pathogenetic …

… and different stimuli and pathogenic factors which trigger the … pathogenesis of the pathological
fibrosis of chronic kidney … , having a great negative kidney and cardiac impact in CKD. …

… in the course of progressive renal disease and in dialysis patients, may considerably
contribute to the progression of atheromatous disease in renal patients. lndeed, Shoij et al. [19] …

… careful use of vitamin K antagonists in patients on dialysis and at high risk of vascular calcifica…
elevated serum levels of total MGP in dialysis patients, since MGP has a molecular weight …

… (dialysis or kidney … pathogenesis, regardless of the initial nosology, are (1) local (in the
kidneys) and systemic chronic low-grade inflammation (ChLGI) as a risk factor for diabetic kidney …

… inflammation in PD patients. More importantly, we provide emerging evidence that shows
the serious consequences of chronic systemic inflammation in PD patients and the important …

… This paper reviews pathogenesis, clinical consequences, and treatment of metabolic acidosis
in CKD. Whether the correction of metabolic acidosis can be connected to the beneficial …